Can price and regulatory controls replace free market competition in the drug industry?
Weil, Gotshal & Manges, Washington, DC.
N L
NL
Buc
G M
GM
Levitt
D016527:Drug Costs / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D004465:Economic Competition / Q000331:legislation & jurisprudence; D018166:Health Care Reform / Q000191:economics / Q000331:legislation & jurisprudence*; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence; D006278:Medicare / Q000331:legislation & jurisprudence; D011306:Prescription Fees / Q000331:legislation & jurisprudence*; D014481:United States